# Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes

> **NCT00336674** · PHASE2 · COMPLETED · sponsor: **Melbourne Health** · enrollment: 110 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **BIOLOGICAL:** Intranasal insulin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00336674
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2019-11-13
- **Final completion:** 2019-11-13
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336674, "Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00336674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*